1	9 patient who have receive live attenuate vaccine within 1 week of start of everolimus and during the study|everolimus[76,86]|||||||1 week[57,63]||C0541315|141704|141704|everolimus
1	9 patient who have receive live attenuate vaccine within 1 week of start of everolimus and during the study|vaccine[42,49]||||||||||11094|11094|vaccine
